Biomarkers and outcome after tamoxifen treatment in node-positive breast cancers from elderly women
2000

Breast Cancer Treatment Outcomes in Elderly Women

Sample size: 145 publication Evidence: moderate

Author Information

Author(s): Daidone M G, Luisi A, Martelli G, Benini E, Veneroni S, Tomasic G, De Palo G, Silvestrini R

Primary Institution: Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy

Hypothesis

The study investigates the predictive role of tumor characteristics on relapse and survival in elderly women with node-positive breast cancer treated with tamoxifen.

Conclusion

Tumor characteristics such as proliferation rate and protein expression can significantly predict relapse and overall survival in elderly women with breast cancer.

Supporting Evidence

  • Patients with rapidly proliferating tumors had a higher probability of relapse.
  • Overexpression of p53 was linked to a significantly higher risk of relapse.
  • Weak or absent bcl-2 expression was associated with increased relapse risk.
  • Lack of estrogen receptors correlated with a higher probability of relapse.
  • Having four or more positive lymph nodes increased the risk of relapse.

Takeaway

This study found that certain features of breast tumors can help doctors predict how likely it is that older women will have problems after treatment.

Methodology

The study analyzed tumor characteristics in elderly patients with node-positive breast cancer who received tamoxifen treatment.

Participant Demographics

Elderly women (≥70 years of age) with node-positive breast cancer.

Statistical Information

P-Value

P = 0.0001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1054/bjoc.1999.0914

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication